Filing Details

Accession Number:
0001209191-23-047025
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-23 16:08:32
Reporting Period:
2023-08-21
Accepted Time:
2023-08-23 16:08:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124140 Exact Sciences Corp EXAS Services-Medical Laboratories (8071) 204782291
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1689757 Thomas Jeffrey Elliott C/O Exact Sciences Corp.
5505 Endeavor Lane
Madison WI 53719
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-02 260 $47.41 29,501 No 5 A Direct
Common Stock Acquisiton 2023-05-01 709 $30.02 30,210 No 5 A Direct
Common Stock Disposition 2023-08-21 30,210 $82.92 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 5 A Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,313 Indirect Held in 401(k) Plan
Footnotes
  1. Represents shares of common stock purchased through Employee Stock Purchase Plan.
  2. The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into on May 24, 2023 and previously disclosed in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2023.
  3. In addition to the shares of Common Stock reported on this Form 4, which total 1,313 shares, Mr. Elliott also holds, in the aggregate, an additional 147,763 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.